StockMarketWire.com - Diagnostics developer for organ transplants Verici said it had initiated its first European clinical validation trial site at the Sant'Orsola polyclinic hospital in Bologna, Italy.

The trial was a global, non-randomised, observational study for the clinical validation of Verici Dx's lead products.


Story provided by StockMarketWire.com